✦ LIBER ✦

An open-label, phase 2 trial of RPI.4610 (angiozyme) in the treatment of metastatic breast cancer

✍ Scribed by Phuong Khanh Morrow; Rashmi K. Murthy; Joe D. Ensor; Gilad S. Gordon; Kim A. Margolin; Anthony D. Elias; Walter J. Urba; David E. Weng; Hope S. Rugo; Gabriel N. Hortobagyi

Book ID: 112067040
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 828 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26730

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of a phase II open-label, nonran

Results of a phase II open-label, nonrandomized trial of oral satraplatin in patients with metastatic breast cancer

✍ John W. Smith; Kristi J. McIntyre; Patrick V. Acevedo; Carlos A. Encarnacion; Ka 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 230 KB

Phase II trial of 10-EDAM in the treatme

Phase II trial of 10-EDAM in the treatment of metastatic breast cancer

✍ Garth A. Beinart; Ana M. Gonzalez-Angulo; Kristine Broglio; Debbie Frye; Ronald 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 273 KB

An open-label, phase 2 trial of denosuma

An open-label, phase 2 trial of denosumab in the treatment of relapsed or plateau-phase multiple myeloma

✍ Ravi Vij; Noemi Horvath; Andrew Spencer; Kerry Taylor; Saroj Vadhan-Raj; Robert 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB 👁 2 views

Results of a phase II open-label, non-ra

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients withBRCA1-positive metastatic breast cancer

✍ Tomasz Byrski, Rebecca Dent, Pawel Blecharz, Malgorzata Foszczynska-Kloda, Jacek 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 269 KB

An Open-label, Single-arm, Phase 2 Trial

An Open-label, Single-arm, Phase 2 Trial of Panitumumab Plus FOLFIRI as Second-line Therapy in Patients with Metastatic Colorectal Cancer

✍ Allen L. Cohn; Grace C. Shumaker; Pankaj Khandelwal; David A. Smith; Marcus A. N 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 429 KB

P.2.089 An open-label, Japanese, phase I

P.2.089 An open-label, Japanese, phase II clinical trial of ziprasidone in the treatment of schizophrenia

✍ M. Murasaki 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 152 KB